Cargando...
A Review on: Phase ‘0’ Clinical Trials or Exploratory Investigational New Drug
In a move to speed up the development of new medicines, the Food and Drug Administration announced in January 2006 the creation of the exploratory Investigational New Drug (IND), the so-called phase ‘0’ clinical trials. This guidance is intended to clarify what preclinical and clinical approaches, a...
Gardado en:
| Publicado en: | Turk J Pharm Sci |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Galenos Publishing
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7227998/ https://ncbi.nlm.nih.gov/pubmed/32454598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjps.63935 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|